435 results
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements … this offering to be used for any particular purpose, our management will have broad discretion as to the application of the net proceeds from
8-K
EX-1.1
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement Shares … unconsolidated entity, including, but not limited to, any structural finance, special purpose or limited purpose entity (each, an “Off-Balance Sheet
424B5
c99lqbpqx8tlk
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-10.1
hush7rrb928y
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
S-8
e1n4tjeggoz8vuxu9zn4
13 Nov 23
Registration of securities for employees
4:19pm
S-8
20cjaj9yuy26moake
13 Nov 23
Registration of securities for employees
4:19pm
S-8
EX-5.1
d38m1irlerbxkc9t581r
13 Nov 23
Registration of securities for employees
4:19pm
8-K
EX-10.1
7bqzr4 5u
7 Jul 22
Departure of Directors or Certain Officers
4:15pm